Skip to main content
Scott Armstrong, MD, Pediatric Hematology & Oncology, Boston, MA, Dana-Farber Cancer Institute

ScottAArmstrongMD

Pediatric Hematology & Oncology • Boston, MA

Associate Professor of Pediatrics, Dana-Farber Cancer Institute

Join to view full profile

Dr. Armstrong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Armstrong's full profile

Already have an account?

Education & Training

  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterResidency, Pediatrics, 1996 - 1998
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 1996

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1998 - 2024
  • NY State Medical License
    NY State Medical License 2014 - 2016

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2010

Publications & Presentations

PubMed

Journal Articles

  • Article HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis  
    Ross L Levine, Jay L Hess, Sheng Cai, Scott A Armstrong, ScienceDirect

Abstracts/Posters

  • A Phase Ib/II Study of the Histone Methyltransferase Inhibitor Pinometostat in Combination with Azacitidine in Patients with 11q23-Rearranged Acute Myeloid Leukemia
    Scott A. Armstrong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Tudor Domain-Focused CRISPR Dropout Screen Identifies SGF29 As a Novel Essential Gene in MLL-Rearranged Leukemias
    Scott A. Armstrong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Leukemia Cell of Origin Influences p53 Activity and Therapeutic Sensitivity Via an Evi1-Dependent Mechanism
    Scott A. Armstrong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Biochemical and Genetic Insights Into MLL/11q23 Translocation Leukemia 
    60th American Society of Hematology Annual Meeting - 12/2/2018
  • High-Density CRISPR Scan Identifies Functional Regions of DOT1L That Mediate Therapeutic Response in MLL-r Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Experimental Pill Sends a Third of Leukemia Patients into Complete Remission in an Early Trial
    Experimental Pill Sends a Third of Leukemia Patients into Complete Remission in an Early TrialMarch 24th, 2023
  • Experimental Pill Sends a THIRD of Patients with Leukemia into Complete Remission in Early Trial
    Experimental Pill Sends a THIRD of Patients with Leukemia into Complete Remission in Early TrialMarch 24th, 2023
  • Stop & Shop Kicks off Annual ‘Help Cure Childhood Cancer’ Campaign
    Stop & Shop Kicks off Annual ‘Help Cure Childhood Cancer’ CampaignMarch 3rd, 2023
  • Join now to see all

Grant Support

  • Molecular Pathogenesis Of MLL-AF4 LeukemiasNational Cancer Institute2010–2012
  • MLL Fusion Genes In Myeloid And Lymphoid LeukemiasNational Cancer Institute2008–2012
  • Comprehensive Phenotypic Comparison Of Normal And Cancer Stem CellsNational Cancer Institute2009–2010
  • The Core Apoptotic Pathway Controlling Glucocorticoid-Induced Apoptosis In AllNational Cancer Institute2006–2010
  • MLL Gene Regulation In Hematopoiesis And LeukemiaNational Cancer Institute2005–2006
  • MLL Gene Regulation In Hematopoiesis And LeukemiaNational Cancer Institute2001–2004

Hospital Affiliations

Dr. Scott Armstrong, Dr. Scott Armstrong, MD, Dr. S Armstrong, Dr. Scott A Armstrong